Press Releases
WALTHAM, Mass., Aug 02, 2011 (BUSINESS WIRE) --
NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Growth Conference at the Intercontinental Boston, Boston, MA on August 9, 2011. Dr. Gozani intends to provide an update on the Company's business activities and on its new product NC-stat® DPNCheckTM for testing of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
NeuroMetrix's presentation is scheduled for Thursday, August 11, 2011 at 8:00 am (Eastern Daylight Time). A live audio webcast will be available on the investor relations section of the corporate website - www.neurometrix.com. This webcast will be archived after the live event.
About NeuroMetrix
NeuroMetrix is a science-based health care company improving patient care through neurotechnology. The company develops and markets innovative products for the detection, diagnosis, and monitoring of peripheral nerve disorders such as those associated with diabetes and carpal tunnel syndrome. For more information, please visit http://www.neurometrix.com.
SOURCE: NeuroMetrix
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
Chief Financial Officer
neurometrix.ir@neurometrix.com